These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12467763)

  • 21. Primary prevention of hepatitis C virus infection.
    Zanetti AR; Romanò L; Bianchi S
    Vaccine; 2003 Jan; 21(7-8):692-5. PubMed ID: 12531341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology and control of hepatitis C infection.
    Gungabissoon U
    Nurs Times; 2003 Aug 5-11; 99(31):24-5. PubMed ID: 13677115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Economic Burden of Hepatitis A, B, and C in South Korea.
    Shon C; Choi HY; Shim JJ; Park SY; Lee KS; Yoon SJ; Oh IH
    Jpn J Infect Dis; 2016; 69(1):18-27. PubMed ID: 25971325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global epidemiology of hepatitis C virus infection.
    Shepard CW; Finelli L; Alter MJ
    Lancet Infect Dis; 2005 Sep; 5(9):558-67. PubMed ID: 16122679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030.
    Sonderup MW; Afihene M; Ally R; Apica B; Awuku Y; Cunha L; Dusheiko G; Gogela N; Lohouès-Kouacou MJ; Lam P; Lesi O; Mbaye PS; Musabeyezu E; Musau B; Ojo O; Rwegasha J; Scholz B; Shewaye AB; Tzeuton C; Kassianides C; Spearman CW;
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):910-919. PubMed ID: 29132760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress toward prevention and control of hepatitis C virus infection--Egypt, 2001-2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jul; 61(29):545-9. PubMed ID: 22832935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y Venezuela.
    Bardach A; Hernández-Vásquez A; Palacios A; Calderón M; Soto N; Balan D; Augustovski F
    Value Health Reg Issues; 2019 Dec; 20():180-190. PubMed ID: 31654963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute hepatitis C virus infection.
    Irving WL; Salmon D; Boucher C; Hoepelman IM
    Euro Surveill; 2008 May; 13(21):. PubMed ID: 18761963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C: What lies ahead and can we afford it?
    Howie H; Hutchinson SJ
    J Viral Hepat; 2004 Sep; 11 Suppl 1():28-33. PubMed ID: 15357861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tracking and treating Hep C infection.
    Rosenberg S; Tarre H
    Bus Health; 1999 Feb; 17(2):41-2. PubMed ID: 10346091
    [No Abstract]   [Full Text] [Related]  

  • 32. CROI 2018: Highlights of Viral Hepatitis.
    Luetkemeyer AF; Wyles DL
    Top Antivir Med; 2018 May; 26(1):30-38. PubMed ID: 29727295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost-effective medical therapy of hepatitis C employing novel compensation models - pay for cure].
    Foerster F; Wörns MA; Galle PR; Schattenberg JM
    Z Gastroenterol; 2015 Dec; 53(12):1414-21. PubMed ID: 26666278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospitalizations and costs associated with hepatitis C and advanced liver disease continue to increase.
    Xu F; Tong X; Leidner AJ
    Health Aff (Millwood); 2014 Oct; 33(10):1728-35. PubMed ID: 25288416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving epidemiology of hepatitis C virus.
    Lavanchy D
    Clin Microbiol Infect; 2011 Feb; 17(2):107-15. PubMed ID: 21091831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus screening to reveal a better picture of infection.
    Medici MC; Galli C; Calderaro A
    Trends Microbiol; 2015 Jun; 23(6):324-6. PubMed ID: 26047087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hepatitis C epidemiology in the world].
    Richard V
    Med Trop (Mars); 1996; 56(4):393-9. PubMed ID: 9139200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.
    Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersma ST
    Hepatology; 2013 Apr; 57(4):1333-42. PubMed ID: 23172780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals.
    Gountas I; Sypsa V; Papatheodoridis G; Souliotis K; Athanasakis K; Razavi H; Hatzakis A
    World J Gastroenterol; 2019 Mar; 25(11):1327-1340. PubMed ID: 30918426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.